| |
| |
|
| Insider
Information: |
Eastbourne Capital Management Llc/ca |
| Relationship: |
10% Owner |
| City: |
San Rafael |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
44,385,290 |
|
|
Indirect Shares
|
48,092,752 |
|
|
| Direct
Value |
$1,036,713,816 |
|
|
|
Indirect Value
|
$579,217,359 |
|
|
| Total
Shares |
92,478,042 |
|
|
| Total
Value |
$1,615,931,175 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cassava Sciences Inc |
SAVA |
10% Owner |
2009-09-29 |
3,230,204 |
2007-12-31 |
10,901,174 |
Premium* |
|
|
Mabvax Therapeutics Holdings Inc |
MBVX |
10% Owner |
2009-09-30 |
11,850,000 |
2010-05-10 |
1,532,709 |
Premium* |
|
|
Amylin Pharmaceuticals Inc |
AMLN |
10% Owner |
2009-09-17 |
13,346,120 |
2007-12-31 |
20,220,126 |
Premium* |
|
|
MGIC Investment Corp |
MTG |
10% Owner |
2009-09-16 |
10,299,755 |
2009-03-11 |
15,438,743 |
Premium* |
|
|
Sarepta Therapeutics Inc |
SRPT |
10% Owner |
2010-03-04 |
5,659,211 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
– – • |
2010-05-10 |
4 |
D |
$0.00 |
$0 |
I/I |
(10,317,291) |
1,532,709 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
– – • |
2008-08-27 |
4 |
S |
$20.07 |
$128,143,018 |
D/D |
(6,026,562) |
17,200,000 |
0 |
- |
|
| MTG |
MGIC Investment Corp |
10% Owner |
– – • |
2009-09-16 |
4 |
S |
$8.96 |
$41,278,295 |
D/D |
(4,600,245) |
10,299,755 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
– – • |
2008-06-23 |
4 |
S |
$1.26 |
$5,368,884 |
D/D |
(4,261,019) |
11,475,000 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
10% Owner |
– – • |
2010-03-04 |
4 |
S |
$1.24 |
$5,077,361 |
D/D |
(4,094,646) |
5,659,211 |
0 |
- |
|
| MTG |
MGIC Investment Corp |
10% Owner |
– – • |
2009-03-12 |
4 |
B |
$0.85 |
$2,551,799 |
D/D |
2,988,158 |
18,500,000 |
2.45 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
– – • |
2009-09-16 |
4 |
S |
$14.09 |
$34,088,489 |
D/D |
(2,410,639) |
14,789,361 |
0 |
- |
|
| MTG |
MGIC Investment Corp |
10% Owner |
– – • |
2009-09-15 |
4 |
S |
$8.72 |
$19,126,709 |
D/D |
(2,100,000) |
14,900,000 |
0 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2009-08-07 |
4 |
S |
$3.96 |
$6,585,480 |
D/D |
(1,663,000) |
6,307,119 |
0 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2009-09-28 |
4 |
S |
$4.98 |
$7,746,226 |
D/D |
(1,556,842) |
3,232,277 |
0 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2009-09-25 |
4 |
S |
$4.98 |
$7,552,050 |
D/D |
(1,518,000) |
4,789,119 |
0 |
- |
|
| MTG |
MGIC Investment Corp |
10% Owner |
– – • |
2009-09-14 |
4 |
S |
$9.10 |
$13,719,925 |
D/D |
(1,500,000) |
17,000,000 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
– – • |
2009-09-17 |
4 |
S |
$13.89 |
$20,124,372 |
D/D |
(1,443,241) |
13,346,120 |
0 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2009-03-02 |
4 |
S |
$3.40 |
$3,577,507 |
D/D |
(1,000,000) |
10,075,874 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
– – • |
2009-09-22 |
4 |
S |
$0.86 |
$826,948 |
D/D |
(948,538) |
12,254,000 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
– – • |
2008-04-21 |
4 |
B |
$28.52 |
$25,521,703 |
D/D |
894,000 |
22,469,910 |
2.45 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2009-04-02 |
4 |
S |
$4.22 |
$2,538,280 |
D/D |
(600,534) |
9,475,340 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
– – • |
2008-12-31 |
4 |
B |
$0.36 |
$178,766 |
D/D |
485,690 |
12,522,075 |
2.45 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
– – • |
2008-12-30 |
4 |
B |
$0.34 |
$146,783 |
D/D |
414,814 |
12,036,385 |
2.45 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2009-07-07 |
4 |
S |
$4.54 |
$1,686,436 |
D/D |
(368,000) |
8,060,897 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
– – • |
2008-04-30 |
4 |
B |
$27.72 |
$9,886,393 |
D/D |
356,652 |
22,826,562 |
2.45 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
10% Owner |
– – • |
2009-11-11 |
4 |
S |
$1.41 |
$473,092 |
D/D |
(333,950) |
13,890,188 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
– – • |
2009-01-22 |
4 |
B |
$0.45 |
$157,911 |
D/D |
322,809 |
13,140,017 |
2.45 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
– – • |
2008-04-11 |
4 |
B |
$29.80 |
$8,723,362 |
D/D |
291,300 |
21,330,442 |
2.45 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2009-06-08 |
4 |
S |
$5.33 |
$1,531,115 |
D/D |
(286,467) |
8,889,407 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
